 And so if you want to deal with this problem adequately, you need to specify what the psychotherapy component is exactly, which MAPS didn't do. And you also want to specify what your MDMA component is supposed to do. What is the working mechanism? How is the client supposed to interact with the clinician and vice versa? During these sessions, you need much more standardization. The second and maybe more important one is that